Cansino Biologics Inc (688185) — Cash Flow Reinvestment Rate

Latest as of September 2025: 1.45x

Cansino Biologics Inc (688185) has a Cash Flow Reinvestment Rate of 1.45x as of September 2025, reinvesting CN¥44.23 Million (capex CN¥44.23 Million ) from operating cash flow of CN¥30.53 Million. Explore Cansino Biologics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

1.45x

(Capex + Investments) / Operating CF

Total Reinvested

CN¥44.23 Million

Capex + Investments

Operating Cash Flow

CN¥30.53 Million

CNY

Capital Expenditures

CN¥44.23 Million

CNY

Cansino Biologics Inc Cash Flow Reinvestment Rate (2021–2021)

Historical reinvestment intensity for Cansino Biologics Inc across 1 annual periods. Also explore Cansino Biologics Inc (688185) total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Cansino Biologics Inc (2021–2021)

Year-by-year capital reinvestment analysis for Cansino Biologics Inc. For live market cap and broader valuation context, see Cansino Biologics Inc stock valuation.

Year	Reinvestment Rate	Total Reinvested (CNY)	Operating CF	Capex	YoY Change
2021	1.29x	CN¥2.61 Billion	CN¥2.01 Billion	CN¥1.20 Billion	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow